Table 2.
Patient 1 | Patient 2 | Patient 3 | Patient 4 | |
---|---|---|---|---|
T2W hyperintense signal: | ||||
Globus pallidi | ++ | ++ | ++ | ++ |
Putamina | + | + | + | + |
Caudate heads | + | + | + | + |
Thalami | − | − | − | + |
Cerebral crura | ++ | ++ | ++ | ++ |
Periaqueductal gray matter | − | + | + | + |
Pons | + | − | − | + |
Cerebellum | − | − | − | + |
Restricted diffusion: | + | + | + | + |
Brain volume loss: | ||||
Supratentoria | ++ | + | ++ | ++ |
Infratentorial | ++ | − | + | + |
MRS (Lactate peak): | + | + | − | + |
Summary | Abnormal bilateral signal in the basal ganglia, midbrain, and dendate. Dilation of ventricles, significant progression in cerebral, and cerebellar atrophy. Thinning of corpus callosum. | Abnormal symmetrical bilateral signal in globus pallidus, putamen, head of caudate nuclei, subthalamic nuclei, and cerebral peduncles. Thalamus spared. No atrophy. | Symmetrical abnormal signal in globus pallidi, cerebral crura, caudate nuclei, putamina, lentiform nuclei. Prominent sulci and volume loss. | Focal bilateral symmetrical lesions in thalami, abnormal signal in lentiform nuclei, and caudate nuclei, dilation of ventricles, prominent sulci, and volume loss. |
+ Positive, ++ Markedly Positive, − Negative; MRS = magnetic resonance spectroscopy.